Toggle light / dark theme

Bridge recombinases, optimized for human cells, enable massive programmable DNA rearrangements

For decades, gene-editing science has been limited to making small, precise edits to human DNA, akin to correcting typos in the genetic code. Arc Institute researchers are changing that paradigm with a universal gene editing system that allows for cutting and pasting of entire genomic paragraphs, rearranging whole chapters, and even restructuring entire passages of the genomic manuscript.

Scientific breakthrough leads to ‘fluorescent biological qubit’ — it could mean turning your cells into quantum sensors

Fluorescent proteins, which can be found in a variety of marine organisms, absorb light at one wavelength and emit it at another, longer wavelength; this is, for instance, what gives some jellyfish the ability to glow. As such, they are used by biologists to tag cells through the genetic encoding and in the fusing of proteins.

The researchers found that the fluorophore in these proteins, which enables the immittance of light, can be used as qubits due to their ability to have a metastable triplet state. This is where a molecule absorbs light and transitions into an excited state with two of its highest-energy electrons in a parallel spin. This lasts for a brief period before decaying. In quantum mechanical terms, the molecule is in a superposition of multiple states at once until directly observed or disrupted by an external interference.

Enhanced CAR T cells emerge from genetic screening

CAR T cells are patient-derived, genetically engineered immune cells. They are “living drugs” and constitute a milestone in modern medicine. Equipping T cells, a key cell type of the immune system, with a “chimeric antigen receptor” (CAR) enables them to specifically recognize and attack cancer cells.

CAR T cell therapy has demonstrated its potential by curing patients with otherwise untreatable blood cancers. But it still fails for most patients, often due to T cell intrinsic dysfunction. To address their current limitations and to make CAR T cells intrinsically stronger, scientists at the CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences and the Medical University of Vienna have developed a new method for systematic discovery of genetic boosters of CAR T cell function.

The new study, published in Nature, introduces CELLFIE, a CAR T cell engineering and high-content CRISPR screening platform, enabling researchers to systematically modify CAR T cells and evaluate their therapeutic potential.

Nectandrin B (Found In Nutmeg) Extends Lifespan As Much As Rapamycin

Join us on Patreon! https://www.patreon.com/MichaelLustgartenPhD

Discount Links/Affiliates:
Blood testing (where I get the majority of my labs): https://www.ultalabtests.com/partners/michaellustgarten.

At-Home Metabolomics: https://www.iollo.com?ref=michael-lustgarten.
Use Code: CONQUERAGING At Checkout.

Clearly Filtered Water Filter: https://get.aspr.app/SHoPY

Epigenetic, Telomere Testing: https://trudiagnostic.com/?irclickid=U-s3Ii2r7xyIU-LSYLyQdQ6…M0&irgwc=1
Use Code: CONQUERAGING

NAD+ Quantification: https://www.jinfiniti.com/intracellular-nad-test/

Novel gene therapy for hereditary hearing loss developed at Tel Aviv University

Scientists from the Gray Faculty of Medical & Health Sciences at Tel Aviv University introduced an innovative gene therapy method to treat impairments in hearing and balance caused by inner ear dysfunction. According to the researchers, “This treatment constitutes an improvement over existing strategies, demonstrating enhanced efficiency and holds promise for treating a wide range of mutations that cause hearing loss.”

The study was led by Prof. Karen Avraham, Dean of the Gray Faculty of Medical & Health Sciences, and Roni Hahn, a PhD student from the Department of Human Molecular Genetics and Biochemistry. The study was conducted in collaboration with Prof. Jeffrey Holt and Dr. Gwenaëlle Géléoc from Boston Children’s Hospital and Harvard Medical School and was supported by the US-Israel Binational Science Foundation (BSF), the National Institutes of Health/NIDCD and the Israel Science Foundation Breakthrough Research Program. The study was featured on the cover of the journal EMBO Molecular Medicine.

Prof. Avraham explains: “The inner ear consists of two highly coordinated systems: the auditory system, which detects, processes, and transmits sound signals to the brain, and the vestibular system, which enables spatial orientation and balance. A wide range of genetic variants in DNA can affect the function of these systems, leading to sensorineural hearing loss and balance problems. Indeed, hearing loss is the most common sensory impairment worldwide, with over half of congenital cases caused by genetic factors. In this study, we aimed to investigate an effective gene therapy for these cases using an approach that has not been applied in this context before.”

Pest resistance threatens corn industry’s newest biotech defense, study warns

Corn rootworms, pests responsible for billions of dollars in yearly crop losses, are evolving resistance that weakens even the latest biotechnology controls, according to a new study published in the journal Proceedings of the National Academy of Sciences.

Drawing on decades of data across multiple states, University of Arizona entomologists found that field-evolved to Bacillus thuringiensis, or Bt, is undermining the effectiveness of corn that targets rootworms with the combination of Bt and RNA interference, or RNAi, a new biotech control that turns the rootworms’ own genetic instructions against them.

The research team analyzed extensive field data collected over the past two decades in 12 previous studies, including millions of rootworms evaluated across the Corn Belt, which extends from western Ohio to eastern Nebraska and northeastern Kansas.

Drinking any amount of alcohol likely increases dementia risk

Drinking any amount of alcohol likely increases the risk of dementia, suggests the largest combined observational and genetic study to date, published in BMJ Evidence-Based Medicine.

Even light drinking—generally thought to be protective, based on observational studies—is unlikely to lower the risk, which rises in tandem with the quantity of alcohol consumed, the research indicates.

Current thinking suggests that there might be an “optimal dose” of alcohol for brain health, but most of these studies have focused on and/or didn’t differentiate between former and lifelong non-drinkers, complicating efforts to infer causality, note the researchers.

Hidden Plant Stem Cells Could Hold the Key to Feeding the Future

Plant scientists discovered hidden stem cell regulators tied to growth and crop size. Their breakthrough could transform how we grow food, fuel, and resilient harvests.

Plant stem cells play a vital role in producing the world’s food, livestock feed, and renewable fuels. They are the foundation of plant growth, yet many aspects of how they work remain a mystery. Past studies have struggled to identify several of the key genes that govern stem cell activity.

Mapping the genetic regulators of growth.

Scientists Advance Prospects for Permanently Putting AIDS Virus into Dormant State Using Gene Therapy

In a study of human immune cells infected with HIV, the virus that causes AIDS, scientists at Johns Hopkins Medicine say a molecule within HIV itself can be manipulated and amplified to force the virus into long-term dormancy, a state in which HIV does not replicate.

The Johns Hopkins team that conducted the new study had previously shown that the molecule of interest, an “antisense transcript,” or AST, is produced by HIV’s genetic material and is part of a molecular pathway that essentially puts the virus to sleep, a state known as viral latency.

The study’s leader, Fabio Romerio, Ph.D., associate professor of molecular and comparative pathobiology at the Johns Hopkins University School of Medicine, says the new findings add to a growing body of evidence that may help researchers develop a gene therapy that boosts AST production. A report on the research, funded by the National Institutes of Health, was published May 9 in Science Advances.

Bilu Huang — CSO, Fuzhuang Therapeutics — Conquering Aging Via TRCS

Conquering aging via TRCS — the telomere DNA AND ribosomal DNA co-regulation model for cell senescence — bilu huang — CSO, fuzhuang therapeutics.


Bilu Huang (https://biluhuang.com/) is a visionary scientist dedicated to finding solutions to some of the most pressing challenges facing humanity. His interdisciplinary work spans multiple fields, including biological aging, dinosaur extinction theories, geoengineering for carbon removal, and controlled nuclear fusion technology.

Born in Sanming City, Fujian Province, Huang is an independent researcher whose knowledge is entirely self-taught. Driven by curiosity and a relentless pursuit of scientific exploration, he has achieved numerous research results through his dedication and passion for science.

As a talented theoretical gerontologist, he proposed the Telomere DNA and ribosomal DNA co-regulation model for cell senescence (TRCS) and he is now using this latest theory to develop biotechnology to rejuvenate cells which will be used to completely cure various age-related degenerative diseases and greatly extend human life at Fuzhuang Therapeutics (https://lab.fuzhuangtx.com/en/).

#Aging #Longevity #BiluHuang #FuzhuangTherapeutics #TelomereDNAAndRibosomalDNACoRegulationModelForCell #Senescence #TRCS #DinosaurExtinctionResearch #CarbonRemovalTechnology #ControlledNuclearFusion #TelomereDNA #RibosomalDNA #CellularAging #GeneticProgram #Telomere #P53

/* */